-
20 Feb 2012
-
11 Jan 2012
-
11 Jan 2012
-
11 Oct 2011
Universal Biosensors today announced that it has commenced a new research and
development project for LifeScan affiliate, Cilag GmbH International
-
20 Sep 2011
Universal Biosensors, Inc. (ASX: UBI) today announced that it has signed a non-exclusive licence
agreement with Australian company, SpeeDx Pty Ltd, for access to its proprietary MNAzyme technology.
-
14 Sep 2011
Universal Biosensors, Inc. (ASX: UBI) today announced that it has been advised that LifeScan has
received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its OneTouch
Verio® blood glucose system
-
09 Sep 2011
-
09 Sep 2011
-
12 Aug 2011
-
12 May 2011
Outcomes of the Universal Biosensors, Inc. 2011 Annual Meeting
-
13 Apr 2011
Universal Biosensors, Inc. (ASX: UBI) today announced that it has been advised by Lifescan that the OneTouch Verio® product has been launched in Germany, the United Kingdom, Ireland, Spain and Portugal.
-
24 Feb 2011
Universal Biosensors, Inc. (ASX: UBI) announced today that, following a global executive search, Mr Paul
Wright had been appointed as Chief Executive Officer, starting from 1 March 2011.
-
01 Feb 2011
Universal Biosensors, Inc. (ASX: UBI) today announced that LifeScan’s new product, OneTouch Verio®
has been made available for sale in France. The OneTouch Verio® incorporates technology developed by
Universal Biosensors and addresses the rapidly growing Self Monitoring Blood Glucose (SMBG) market.
-
31 Dec 2010
Universal Biosensors, Inc. (ASX: UBI) today announced that LifeScan's new product, OneTouch Verio®
has been made available for sale in Italy. The OneTouch Verio® incorporates technology developed by
Universal Biosensors and addresses the rapidly growing Self Monitoring Blood Glucose (SMBG) market.
-
31 Dec 2010
This report is to be read in conjunction with any public announcements made during the
reporting period in accordance with the continuous disclosure requirements of the
Corporations Act 2001 (Cth) and the Listing Rules of the Australian Securities Exchange.
-
31 Dec 2010
Universal Biosensors, Inc. (ASX: UBI) has been advised by LifeScan, Inc. that LifeScan has been granted
regulatory clearance to sell the OneTouch Verio® product as sold in Australia by the United States Food
and Drug Administration.
-
29 Nov 2010
Universal Biosensors, Inc. (ASX: UBI) today announced positive results in a clinical study assessing the
performance of its next major point of care technology, the PT/INR strip and meter system. The system
prototype showed excellent correlation with the current market leader in the US$400m
-
09 Sep 2010
Mr. Morrisson announced today his decision to retire as Chief Executive Officer of Universal Biosensors,
Inc. (ASX: UBI) and to resign from the Company’s Board of Directors.
-
09 Aug 2010
Universal Biosensors, Inc. (ASX: UBI) announced today that it has been informed by LifeScan (a Johnson
& Johnson company), that LifeScan’s new product incorporating technology developed with Universal
Biosensors will be made available for sale in Australia under the OneTouch® Verio™ brand from the 1st of
September 2010.
-
15 Jun 2010
Universal Biosensors, Inc. (ASX: UBI) announced today that LifeScan, Inc had provided information concerning its strategic intentions for Its OneTouch® Verio™ product developed with UBI.
-
13 May 2010
In accordance with Listing Rule 3.13.2 of the Listing Rules of Australian Securities Exchange, Universal Biosensor, Inc. advises that all resolutions set out in the Proxy Statement dated 19 March 2010 and considered at the annual meeting of Universal Biosensors, Inc. held 13 May 2010 were passed by way of poll.
-
28 Jan 2010
Universal Biosensors, Inc. (ASX: UBI) announces that it has been informed by its partner LifeScan, Inc that
LifeScan’s new product incorporating technology developed by UBI has been made available for sale in
The Netherlands under the One Touch “Verio” brand (www.lifescan.nl). CE marking for the product was
approved in November.
-
11 Jan 2010
Universal Biosensors, Inc. (ASX: UBI) announced today a change to its board of directors with the
appointment of Mr Marshall Heinberg and the retirement of Mr Charles Kiefel.
-
11 Dec 2009
Universal Biosensors, Inc. (ASX: UBI) announced today a change to its board of directors with the
appointment of Mr Marshall Heinberg and the retirement of Mr Charles Kiefel.
-
10 Nov 2009
Universal Biosensors, Inc. (ASX: UBI) reports that it has been advised by LifeScan, Inc. that an initial
regulatory clearance to sell has been granted for the blood glucose monitoring product developed with
UBI.